.
.
.
.

Abbott completes India recall of baby formula products imported from US

Published: Updated:

Abbott Laboratories’ India unit has completed a recall of baby formula products that were manufactured at the company’s troubled Michigan facility in the United States, a spokesperson for the company said on Friday.

“The voluntary recall in India impacted Alimentum and EleCare (brands). No other Abbott nutrition products, or Similac products, distributed in India were affected by the recall,” the spokesperson told Reuters.

For the latest headlines, follow our Google News channel online or via the app.

Abbott said earlier this week it had reached an agreement with the US health regulator to resume production at the Michigan plant, which has been shut down over reports of bacterial infections in infants who had consumed products made at the facility.

The company recalled dozens of types of Similac, Alimentum and EleCare powdered formulas in the US and internationally following the infections.

Similac supplied in India is produced at Abbott’s plant in the country’s western state of Gujarat.

The Food Safety and Standards Authority of India has been informed about the recall, according to the spokesperson.

The recall in February by Abbott in the United States created one of the most urgent food shortages in recent history for US families, with other baby formula makers stepping up shipments to the country.

Read more: Nestle airlifts baby formula to US from Europe to ease shortage

Top Content Trending